You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TARS Sale Disclosure
Lin Elizabeth Yeu · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$339.83K
Lin Elizabeth Yeu Chief Medical Officer
TARS
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
TARS daily price context
Close on/before transaction
$74.05
Sep 1, 2026
First close after public filing
$90.78
Sep 4, 2026
30-day return after filing
-17.98%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,601 shares @ $73.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001842190-26-000009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$897.99K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Sale | Sep 2, 2026 | $430.96K |
| Tarsus Pharmaceuticals, Inc. TARS | Sale | Sep 2, 2026 | $127.2K |
| Tarsus Pharmaceuticals, Inc. TARS Current | Sale | Sep 1, 2026 | $339.83K |